SXC 2023
CAS No. 1695562-36-7
SXC 2023 ( —— )
产品货号. M36974 CAS No. 1695562-36-7
SXC 2023 ((S)-2-acetamido-3-(4-methylbenzoylthio)propanoic acid) is a therapeutic prodrug of N-acetyl-L-cysteine for the treatment of CNS disorders and neurocognitive disorders, and can be used to treat glutamatergic dysfunction and psychiatric disorders in which oxidative stress plays a key role.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥208 | 有现货 |
|
| 10MG | ¥297 | 有现货 |
|
| 25MG | ¥460 | 有现货 |
|
| 50MG | ¥737 | 有现货 |
|
| 100MG | ¥1224 | 有现货 |
|
| 200MG | ¥1782 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称SXC 2023
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述SXC 2023 ((S)-2-acetamido-3-(4-methylbenzoylthio)propanoic acid) is a therapeutic prodrug of N-acetyl-L-cysteine for the treatment of CNS disorders and neurocognitive disorders, and can be used to treat glutamatergic dysfunction and psychiatric disorders in which oxidative stress plays a key role.
-
产品描述SXC 2023 ((S)-2-acetamido-3-(4-methylbenzoylthio)propanoic acid) is a therapeutic prodrug of N-acetyl-L-cysteine for the treatment of CNS disorders and neurocognitive disorders, and can be used to treat glutamatergic dysfunction and psychiatric disorders in which oxidative stress plays a key role.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体Others
-
研究领域——
-
适应症——
化学信息
-
CAS Number1695562-36-7
-
分子量281.33
-
分子式C13H15NO4S
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESC(SC[C@H](NC(C)=O)C(O)=O)(=O)C1=CC=C(C)C=C1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册
关联产品
-
SC-52012
SC-52012 是一种可口服的纤维蛋白原受体 (fibrinogen receptor) 拮抗剂,具有抗血小板的活性。
-
IST5-002
IST5-002,一种有效的 Stat5a/b 抑制剂,选择性地抑制 Stat5a/b 的转录活性,IC50 值分别为 1.5 μM (Stat5a) 和 3.5 μM (Stat5b)。 IST5-002 诱导前列腺癌细胞和慢性粒细胞白血病 (CML) 细胞凋亡 (apoptotic) 和死亡。IST5-002 可用于前列腺癌和慢性粒细胞白血病 (CML) 的研究。
-
(S)-1-Benzylpyrrolid...
(S)-1-Benzylpyrrolidin-3-ol (化合物 14) 可用于合成抗高血压活性分子盐酸巴尼地平 (Barnidipine hydrochloride (HY-107322)) 的杂质。
021-51111890
购物车()
sales@molnova.cn

